BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 25315097)

  • 1. Avoiding detrimental human immune response against Mammalian extracellular matrix implants.
    Galili U
    Tissue Eng Part B Rev; 2015 Apr; 21(2):231-41. PubMed ID: 25315097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acceleration of wound healing by α-gal nanoparticles interacting with the natural anti-Gal antibody.
    Galili U
    J Immunol Res; 2015; 2015():589648. PubMed ID: 25922849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced Remodeling of Porcine Tendons to Human Anterior Cruciate Ligaments by α-GAL Epitope Removal and Partial Cross-Linking.
    Stone KR; Walgenbach A; Galili U
    Tissue Eng Part B Rev; 2017 Aug; 23(4):412-419. PubMed ID: 28068870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U
    Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated healing of skin burns by anti-Gal/alpha-gal liposomes interaction.
    Galili U; Wigglesworth K; Abdel-Motal UM
    Burns; 2010 Mar; 36(2):239-51. PubMed ID: 19501971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α1,3Galactosyltransferase knockout pigs produce the natural anti-Gal antibody and simulate the evolutionary appearance of this antibody in primates.
    Galili U
    Xenotransplantation; 2013; 20(5):267-76. PubMed ID: 23968556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-Gal Nanoparticles Mediated Homing of Endogenous Stem Cells for Repair and Regeneration of External and Internal Injuries by Localized Complement Activation and Macrophage Recruitment.
    Galili U; Goldufsky JW; Schaer GL
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy.
    Galili U
    Immunol Cell Biol; 2005 Dec; 83(6):674-86. PubMed ID: 16266320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.
    LaTemple DC; Abrams JT; Zhang SY; Galili U
    Cancer Res; 1999 Jul; 59(14):3417-23. PubMed ID: 10416604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biosynthesis of α-Gal Epitopes (Galα1-3Galβ1-4GlcNAc-R) and Their Unique Potential in Future α-Gal Therapies.
    Galili U
    Front Mol Biosci; 2021; 8():746883. PubMed ID: 34805272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer immunotherapy for pancreatic cancer utilizing α-gal epitope/natural anti-Gal antibody reaction.
    Tanemura M; Miyoshi E; Nagano H; Eguchi H; Matsunami K; Taniyama K; Hatanaka N; Akamatsu H; Mori M; Doki Y
    World J Gastroenterol; 2015 Oct; 21(40):11396-410. PubMed ID: 26523105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-Gal: an abundant human natural antibody of multiple pathogeneses and clinical benefits.
    Galili U
    Immunology; 2013 Sep; 140(1):1-11. PubMed ID: 23578170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α-Gal Nanoparticles in Wound and Burn Healing Acceleration.
    Galili U
    Adv Wound Care (New Rochelle); 2017 Mar; 6(3):81-92. PubMed ID: 28289553
    [No Abstract]   [Full Text] [Related]  

  • 14. Rapid recruitment and activation of macrophages by anti-Gal/α-Gal liposome interaction accelerates wound healing.
    Wigglesworth KM; Racki WJ; Mishra R; Szomolanyi-Tsuda E; Greiner DL; Galili U
    J Immunol; 2011 Apr; 186(7):4422-32. PubMed ID: 21357545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated Burn Healing in a Mouse Experimental Model Using α-Gal Nanoparticles.
    Galili U
    Bioengineering (Basel); 2023 Oct; 10(10):. PubMed ID: 37892895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing Efficacy of Enveloped Whole-Virus Vaccines by In situ Immune-Complexing with the Natural Anti-Gal Antibody.
    Galili U
    Med Res Arch; 2021 Jul; 9(7):. PubMed ID: 34853815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-mediated accommodation of heart grafts expressing an incompatible carbohydrate antigen.
    Mohiuddin MM; Ogawa H; Yin DP; Shen J; Galili U
    Transplantation; 2003 Feb; 75(3):258-62. PubMed ID: 12589143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential immune responses to alpha-gal epitopes on xenografts and allografts: implications for accommodation in xenotransplantation.
    Tanemura M; Yin D; Chong AS; Galili U
    J Clin Invest; 2000 Feb; 105(3):301-10. PubMed ID: 10675356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo targeting of vaccinating tumor cells to antigen-presenting cells by a gene therapy method with adenovirus containing the alpha1,3galactosyltransferase gene.
    Deriy L; Ogawa H; Gao GP; Galili U
    Cancer Gene Ther; 2005 Jun; 12(6):528-39. PubMed ID: 15818383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xenogeneic thyroid-stimulating hormone-like activity of the human natural anti-Gal antibody. Interaction of anti-Gal with porcine thyrocytes and with recombinant human thyroid-stimulating hormone receptors expressed on mouse cells.
    Winand RJ; Anaraki F; Etienne-Decerf J; Galili U
    J Immunol; 1993 Oct; 151(7):3923-34. PubMed ID: 8104224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.